Music Tuned to 440 Hz Versus 432 Hz and the Health Effects: A Double-blind Cross-over Pilot Study.


Journal

Explore (New York, N.Y.)
ISSN: 1878-7541
Titre abrégé: Explore (NY)
Pays: United States
ID NLM: 101233160

Informations de publication

Date de publication:
Historique:
received: 06 08 2018
revised: 24 03 2019
accepted: 02 04 2019
pubmed: 30 4 2019
medline: 1 7 2020
entrez: 30 4 2019
Statut: ppublish

Résumé

The current reference frequency for tuning musical instruments is 440 Hz. Some theorists and musicians claim that the 432 Hz tuning has better effects on the human body, but there are no scientific studies that support this hypothesis. To identify differences in vital parameters and perceptions after listening to music at different frequencies, 440 Hz versus 432 Hz. Cross-over pilot study. A room dedicated to listening to music, in an Italian city. 33 volunteers, not suffering from acute and/or chronic diseases. Two sessions of music listening on different days. Both sessions used the same music (movie soundtracks) but tuned to 440 Hz on one day and 432 Hz on the other. Each session consisted of 20 min' listening. Vital parameters (blood pressure, heart rate, respiratory rate, oxygen saturation), perceptions (physical and emotional sensations, for example fatigue and stress), levels of concentration during the listening session, and general satisfaction with the experience. 432 Hz tuned music was associated with a slight decrease of mean (systolic and diastolic) blood pressure values (although not significant), a marked decrease in the mean of heart rate (-4.79 bpm, p = 0.05) and a slight decrease of the mean respiratory rate values (1 r.a., p = 0.06), compared to 440 Hz. The subjects were more focused about listening to music and more generally satisfied after the sessions in which they listened to 432 Hz tuned music. The data suggests that 432 Hz tuned music can decrease heart rate more than 440 Hz tuned music. The study results suggest repeating the experiment with a larger sample pool and introducing randomized controlled trials covering more clinical parameters.

Identifiants

pubmed: 31031095
pii: S1550-8307(18)30276-3
doi: 10.1016/j.explore.2019.04.001
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

283-290

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Diletta Calamassi (D)

University of Florence, Italy. Electronic address: diletta.calamassi@gmail.com.

Gian Paolo Pomponi (GP)

Independent musician, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH